feed,title,long_url,short_url
Benzinga,"Stoke Therapeutics' Anti-Epilepsy Drug Candidate Shows Substantial, Sustained Reductions In Seizure Frequency In Pretreated Patients",https://benzinga.com/general/biotech/24/03/37934141/stoke-therapeutics-anti-epilepsy-drug-candidate-shows-substantial-sustained-reductions-in-seizure,https://da.gd/pEN7W
